BMRN vs TCBIO · P/E 40, rev $1.76B vs P/E 5.2, $3.31B cap
Biomarin Pharmaceutical Inc (BMRN) versus Texas Capital Bancshares, Inc. (TCBIO) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Texas Capital Bancshares, Inc. (TCBIO) is a banks - regional company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
TCBIO does not have a complete income-statement cache yet.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. TCBIO currently screens at market cap $3.31B and trailing P/E 5.2.
Not investment advice. Open the BMRN and TCBIO stock pages for the full models.
Not investment advice.